# Nitroprusside Combined with Leg Raise at the Time of Right Heart Catheterization to Differentiate Precapillary from Other Hemodynamic Forms of Pulmonary Hypertension: A Single-Center Pilot Study

**Authors:** Mostafa Naguib, Ahmed Aljwaid, Dean Marella, Raul J. Flores, Abhishek Singh

PMC · DOI: 10.3390/jcdd11040124 · Journal of Cardiovascular Development and Disease · 2024-04-19

## TL;DR

This study explores using nitroprusside and leg raises during heart catheterization to better identify a specific type of pulmonary hypertension for targeted treatment.

## Contribution

A novel approach combining nitroprusside and leg raise to differentiate precapillary from postcapillary pulmonary hypertension during catheterization.

## Key findings

- Nitroprusside and leg raise reduced PCWP, identifying a precapillary-dominant phenotype.
- Patients on PH therapy showed improved exercise capacity and risk scores.
- Dynamic preload assessment improved PH classification accuracy.

## Abstract

Pulmonary hypertension (PH) can arise from several distinct disease processes, with a percentage presenting with combined pre- and postcapillary pulmonary hypertension (cpcPH). Patients with cpcPH are unsuitable candidates for PH-directed therapies due to elevated pulmonary capillary wedge pressures (PCWPs); however, the PCWP is dynamic and is affected by both preload and afterload. Many patients that are diagnosed with cpcPH are hypertensive at the time of right heart catheterization which has the potential to increase the PCWP and, therefore, mimic a more postcapillary-predominant phenotype. In this small pilot study, we examine the effect of nitroprusside combined with dynamic preload augmentation with a passive leg raise maneuver in hypertensive cpcPH patients at the time of right heart catheterization to identify a more precapillary-dominant PH phenotype. Patients that met the criteria of PCWP ≤ 15 mmHg with nitroprusside infusion and PCWP ≤ 18 mmHg with nitroprusside infusion and simultaneous leg raise were started on pulmonary vascular-targeted therapy. Long-term PH therapy was well tolerated, with increased six-minute walk distance, improved WHO functional class, decreased NT-proBNP, and improved REVEAL 2.0 Lite Risk Score in this precapillary-dominant PH phenotype. This small study highlights the importance of characterizing patient physiology beyond resting conditions at the time of right heart catheterization.

## Linked entities

- **Diseases:** pulmonary hypertension (MONDO:0005149)

## Full-text entities

- **Diseases:** PH (MESH:D006976), hypertensive (MESH:D006973), cpcPH (MESH:D058246)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11050046/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11050046/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC11050046/full.md

---
Source: https://tomesphere.com/paper/PMC11050046